MedTrace Logo

Cryotherapy -BEATS-RF Ablation Trial

NCT01882478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2021-10-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether cryotherapy is effective in the treatment of persistent high grade dysplasia (HGD) or early esophageal adenocarcinoma (IMCA) in patients who have not responded to radiofrequency ablation (RFA).

Conditions

  • Barrett's Esophagus With Persistent Dysplasia or
  • Early Esophageal Adenocarcinoma Post Radio Frequency Ablation

Sponsors & Collaborators

Principal Investigators

  • Kenneth K Wang, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01882478 on ClinicalTrials.gov